⭐ Summit Therapeutics, Inc.  has reportedly been in partnership discussions with  AstraZeneca  and other major pharma companies for its...

📢  AbbVie  is set to acquire  University of Pennsylvania ’s spinout,  Capstan Therapeutics  for up to $2.1 billion in cash, representing...

🤝  Bristol Myers Squibb  is set to acquire  2seventy bio  in an all-cash transaction valued at approximately $286 million. After...

📢 The U.S. FDA launched a new program - the Commissioner’s National Priority Voucher (CNPV) - to shorten review timelines from 10-12...

⭐  BioNTech SE  and  Bristol Myers Squibb  entered into a global strategic partnership with a 50/50 profit/loss split to co-develop and...

“The right target, at the right time, for the right price”  …is and always has been a guiding principle for Merck KGaA, as stated by its...